Anti-Fli-1 compounds had been discovered and demonstrated strong anti-leukemic activity in a mouse erythroleukemia model that overexpresses Fli-1, making it possible for targeting Fli-1 as a potent treatment strategy [23]. Here, FLI1 is linked to erythroleukemia.